Found: 28
Select item for more details and to access through your institution.
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45835-6
- By:
- Publication type:
- Article
A genomic score to predict local control among patients with brain metastases managed with radiation.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 10, p. 1815, doi. 10.1093/neuonc/noad098
- By:
- Publication type:
- Article
Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 5, p. 973, doi. 10.1093/neuonc/noac249
- By:
- Publication type:
- Article
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29498-9
- By:
- Publication type:
- Article
A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 1, p. e220603, doi. 10.1001/jamahealthforum.2022.0603
- By:
- Publication type:
- Article
cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries.
- Published in:
- BMC Bioinformatics, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12859-021-04529-2
- By:
- Publication type:
- Article
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 411, doi. 10.1007/s10549-021-06329-x
- By:
- Publication type:
- Article
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 7, p. 1659, doi. 10.3390/cells10071659
- By:
- Publication type:
- Article
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0075-5
- By:
- Publication type:
- Article
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 401, doi. 10.1634/theoncologist.2017-0691
- By:
- Publication type:
- Article
Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 10, p. 1605, doi. 10.1373/clinchem.2017.272849
- By:
- Publication type:
- Article
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 402, p. 1, doi. 10.1126/scitranslmed.aai7993
- By:
- Publication type:
- Article
Systematic genomic and translational efficiency studies of uveal melanoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178189
- By:
- Publication type:
- Article
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
- Published in:
- Genome Medicine, 2016, v. 8, p. 1, doi. 10.1186/s13073-016-0333-9
- By:
- Publication type:
- Article
Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1108, doi. 10.1007/s10637-015-0269-8
- By:
- Publication type:
- Article
Precision Medicine in Breast Cancer: Genes, Genomes, and the Future of Genomically Driven Treatments.
- Published in:
- Current Oncology Reports, 2015, v. 17, n. 4, p. 1, doi. 10.1007/s11912-015-0438-0
- By:
- Publication type:
- Article
Assessing the clinical utility of cancer genomic and proteomic data across tumor types.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 7, p. 644, doi. 10.1038/nbt.2940
- By:
- Publication type:
- Article
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-141
- By:
- Publication type:
- Article
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.
- Published in:
- Nature Medicine, 2014, v. 20, n. 6, p. 682, doi. 10.1038/nm.3559
- By:
- Publication type:
- Article
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 1, p. 178, doi. 10.1007/s10637-013-0045-6
- By:
- Publication type:
- Article
Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Oncogenic mutations in cervical cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 21, p. 3776, doi. 10.1002/cncr.28288
- By:
- Publication type:
- Article
Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor--2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 254, doi. 10.1016/j.clbc.2013.02.010
- By:
- Publication type:
- Article
Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Melanoma genome sequencing reveals frequent PREX2 mutations.
- Published in:
- Nature, 2012, v. 485, n. 7399, p. 502, doi. 10.1038/nature11071
- By:
- Publication type:
- Article
Biomarker-based prediction of response to therapy for colorectal cancer: current perspective.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Using Hospital Tumor Registries to Identify Research Subjects.
- Published in:
- Health Services & Outcomes Research Methodology, 2001, v. 2, n. 1, p. 67, doi. 10.1023/A:1011432302562
- By:
- Publication type:
- Article